흉부 배액 기기 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2031년)

Chest Drainage Devices Market (Product: Thoracic Drainage Systems, Trocar Drains, Unsecured Needles, Secured Needles, Pleural Drainage Catheters, & Thoracic Drainage Kits)-Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2023-2031

US $ 5,795 ￦ 8,384,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795 ￦ 12,725,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795 ￦ 17,066,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

흉부 배액 기기 시장 - 리포트의 범위

세계의 흉부 배액 기기 시장에 관한 TMR의 리포트는 과거와 현재의 성장 동향 및 2023-2031년의 예측 기간 중 시장 지표의 귀중한 인사이트를 얻을 기회를 연구하고 있습니다. 리포트는 세계의 흉부 배액 기기 매출을 제공합니다. 2023년을 기준년, 2031년을 예측년으로 간주하고, 2017-2031년 기간 시장을 분석합니다. 이 리포트는 2023-2031년 세계의 흉부 배액 기기 시장의 연평균 성장률(CAGR %)도 제공합니다.

이 리포트는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서는 조사 활동의 대부분이 시행되고, 애널리스트가 주요 오피니언 리더, 업계 리더, 오피니언 제조업체와 인터뷰를 진행했습니다. 2차 조사에는 흉부 배액 기기 시장을 이해하기 위해 주요 기업의 제품 문헌, 연차보고서, 프레스 릴리스 및 관련 문서 참조가 포함됩니다.

시장 스냅숏
2023년 시장 가치	7억 9,960만 달러
2031년 시장 가치	13억 달러
CAGR	5.4%

이 리포트는 세계의 흉부 배액 기기 시장의 경쟁 구도를 상세 분석하고 있습니다. 세계의 흉부 배액 기기 시장에서 활동하는 주요 기업이 식별되고, 이 각각이 다양한 속성의 측면에서 프로파일링되고 있습니다. 회사 개요, 재무 상황, 최근 동향, SWOT는 이 리포트에서 소개되고 있는 세계의 흉부 배액 기기 시장에서 기업의 속성입니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

• 서론
• 개요
• 시장 역학
• 세계 시장의 분석과 예측, 2017-2031년
• Porter's Five Forces 분석

제5장 주요 인사이트

• 기술의 진보
• 가격 분석
• 주요 제품/브랜드 분석
• COVID-19 팬데믹이 업계에 미치는 영향

제6장 세계 시장의 분석과 예측 : 제품별

• 서론과 정의
• 주요 발견과 개발
• 시장 가치와 수량 예측 : 제품별, 2017-2031
  • 흉강 배액 시스템
    • 아날로그
    • 디지털
  • 투관침 드레인
  • 고정되어 있지 않은 바늘
  • 고정된 바늘
  • 흉강 배액 카테터
    • PVC
    • 기타
  • 흉강 배액 키트
• 시장의 매력 분석 : 제품별

제7장 세계 시장의 분석과 예측 : 용도별

• 서론과 정의
• 주요 발견과 개발
• 시장 금액 예측 : 용도별, 2017-2031
  • 흉부외과와 호흡기과
  • 심장 수술
  • 일반 집중 치료 및 응급의료
  • 감염증
  • 종양학과 통증 관리
  • 군/피해 관리/재해 의료
• 시장의 매력 분석 : 용도별

제8장 세계 시장의 분석과 예측 : 최종사용자별

• 서론과 정의
• 주요 발견과 개발
• 시장 금액 예측 : 최종사용자별, 2017-2031
  • 병원과 전문 클리닉
  • 응급 치료 또는 외래 치료
  • 외래 수술 센터
  • 군 의료시설
  • 구급차 서비스
• 시장의 매력 분석 : 최종사용자별

제9장 세계 시장의 분석과 예측 : 지역별

• 주요 조사 결과
• 시장 금액 예측 : 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 시장의 매력 분석 : 지역별

제10장 북미 시장 분석과 예측

제11장 미국 시장 분석과 예측

제12장 유럽 시장 분석과 예측

제13장 독일 시장 분석과 예측

제14장 영국 시장 분석과 예측

제15장 프랑스 시장 분석과 예측

제16장 스페인 시장 분석과 예측

제17장 아시아태평양 시장 분석과 예측

제18장 라틴아메리카 시장 분석과 예측

제19장 중동 및 아프리카 시장 분석과 예측

제20장 경쟁 구도

• 시장 기업 - 경쟁 매트릭스(기업의 계층 및 규모별)
• 기업별 시장 점유율 분석(2022)
• 제품 카테고리별 주요 기업의 리스트
• 기업 개요
  • ATMOS MedizinTechnik GmbH &Co. KG
  • Becton, Dickinson and Company(BD)
  • Cardinal Health, Inc.
  • Cook Medical
  • Getinge AB
  • ICU Medical, Inc.
  • Medela AG
  • Medtronic
  • Redax Spa
  • Rocket Medical plc.
  • Sinapi Biomedical
  • Teleflex Incorporated
  • Vygon SAS

KSA

영문 목차

영문목차

Chest Drainage Devices Market - Scope of Report

TMR's report on the global chest drainage devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global chest drainage devices market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global chest drainage devices market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the chest drainage devices market.

Market Snapshot
Market Value in 2023	US$ 799.6 Mn
Market Value in 2031	US$ 1.3 Bn
CAGR	5.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global chest drainage devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global chest drainage devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global chest drainage devices market.

The report delves into the competitive landscape of the global chest drainage devices market. Key players operating in the global chest drainage devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global chest drainage devices market profiled in this report.

Key Questions Answered in Global Chest Drainage Devices Market Report:

• What is the sales/revenue generated by chest drainage devices across all regions during the forecast period?
• What are the opportunities in the global chest drainage devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Chest Drainage Devices Market - Research Objectives and Research Approach

The comprehensive report on the global chest drainage devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global chest drainage devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global chest drainage devices market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Chest Drainage Devices Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Definition
  • 4.1.2. Industry Evolution / Development
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Chest Drainage Devices Market Analysis and Forecast, 2017-2031
  • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.4.2. Market Volume/Unit Shipments Projections
• 4.5. Porter's Five Force Analysis

5. Key Insights

• 5.1. Technological Advancements
• 5.2. Pricing Analysis
• 5.3. Key Product/Brand Analysis
• 5.4. COVID-19 Pandemic Impact on Industry

6. Global Chest Drainage Devices Market Analysis and Forecast, by Product

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value & Volume Forecast, by Product, 2017-2031
  • 6.3.1. Thoracic Drainage Systems
    • 6.3.1.1. Analog
    • 6.3.1.2. Digital
  • 6.3.2. Trocar Drains
  • 6.3.3. Unsecured Needles
  • 6.3.4. Secured Needles
  • 6.3.5. Pleural Drainage Catheters
    • 6.3.5.1. PVC
    • 6.3.5.2. Others
  • 6.3.6. Thoracic Drainage Kits
• 6.4. Market Attractiveness Analysis, by Product

7. Global Chest Drainage Devices Market Analysis and Forecast, by Application

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast, by Application, 2017-2031
  • 7.3.1. Thoracic Surgeries & Pulmonology
  • 7.3.2. Cardiac Surgeries
  • 7.3.3. General Intensive Care & Emergency Medicine
  • 7.3.4. Infectious Diseases
  • 7.3.5. Oncology & Pain Management
  • 7.3.6. Military/Damage Control/Disaster Medicine
• 7.4. Market Attractiveness Analysis, by Application

8. Global Chest Drainage Devices Market Analysis and Forecast, by End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast, by End-user, 2017-2031
  • 8.3.1. Hospitals & Specialty Clinics
  • 8.3.2. Urgent Care or Outpatient Care
  • 8.3.3. Ambulatory Surgical Centers
  • 8.3.4. Military Medical Facilities
  • 8.3.5. Ambulance Services
• 8.4. Market Attractiveness Analysis, by End-user

9. Global Chest Drainage Devices Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value Forecast, by Region
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness Analysis, by Region

10. North America Chest Drainage Devices Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value & Volume Forecast, by Product, 2017-2031
  • 10.2.1. Thoracic Drainage Systems
    • 10.2.1.1. Analog
    • 10.2.1.2. Digital
  • 10.2.2. Trocar Drains
  • 10.2.3. Unsecured Needles
  • 10.2.4. Secured Needles
  • 10.2.5. Pleural Drainage Catheters
    • 10.2.5.1. PVC
    • 10.2.5.2. Others
  • 10.2.6. Thoracic Drainage Kits
• 10.3. Market Value Forecast, by Application, 2017-2031
  • 10.3.1. Thoracic Surgeries & Pulmonology
  • 10.3.2. Cardiac Surgeries
  • 10.3.3. General Intensive Care & Emergency Medicine
  • 10.3.4. Infectious Diseases
  • 10.3.5. Oncology & Pain Management
  • 10.3.6. Military/Damage Control/Disaster Medicine
• 10.4. Market Value Forecast, by End-user, 2017-2031
  • 10.4.1. Hospitals & Specialty Clinics
  • 10.4.2. Urgent Care or Outpatient Care
  • 10.4.3. Ambulatory Surgical Centers
  • 10.4.4. Military Medical Facilities
  • 10.4.5. Ambulance Services
• 10.5. Market Value Forecast, by Country, 2017-2031
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Product
  • 10.6.2. By Application
  • 10.6.3. By End-user
  • 10.6.4. By Country

11. U.S. Chest Drainage Devices Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value & Volume Forecast, by Product, 2017-2031
  • 11.2.1. Thoracic Drainage Systems
    • 11.2.1.1. Analog
    • 11.2.1.2. Digital
  • 11.2.2. Trocar Drains
  • 11.2.3. Unsecured Needles
  • 11.2.4. Secured Needles
  • 11.2.5. Pleural Drainage Catheters
    • 11.2.5.1. PVC
    • 11.2.5.2. Others
  • 11.2.6. Thoracic Drainage Kits
• 11.3. Market Value Forecast, by Application, 2017-2031
  • 11.3.1. Thoracic Surgeries & Pulmonology
  • 11.3.2. Cardiac Surgeries
  • 11.3.3. General Intensive Care & Emergency Medicine
  • 11.3.4. Infectious Diseases
  • 11.3.5. Oncology & Pain Management
  • 11.3.6. Military/Damage Control/Disaster Medicine
• 11.4. Market Value Forecast, by End-user, 2017-2031
  • 11.4.1. Hospitals & Specialty Clinics
  • 11.4.2. Urgent Care or Outpatient Care
  • 11.4.3. Ambulatory Surgical Centers
  • 11.4.4. Military Medical Facilities
  • 11.4.5. Ambulance Services
• 11.5. Market Attractiveness Analysis
  • 11.5.1. By Product
  • 11.5.2. By Application
  • 11.5.3. By End-user

12. Europe Chest Drainage Devices Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value & Volume Forecast, by Product, 2017-2031
  • 12.2.1. Thoracic Drainage Systems
    • 12.2.1.1. Analog
    • 12.2.1.2. Digital
  • 12.2.2. Trocar Drains
  • 12.2.3. Unsecured Needles
  • 12.2.4. Secured Needles
  • 12.2.5. Pleural Drainage Catheters
    • 12.2.5.1. PVC
    • 12.2.5.2. Others
  • 12.2.6. Thoracic Drainage Kits
• 12.3. Market Value Forecast, by Application, 2017-2031
  • 12.3.1. Thoracic Surgeries & Pulmonology
  • 12.3.2. Cardiac Surgeries
  • 12.3.3. General Intensive Care & Emergency Medicine
  • 12.3.4. Infectious Diseases
  • 12.3.5. Oncology & Pain Management
  • 12.3.6. Military/Damage Control/Disaster Medicine
• 12.4. Market Value Forecast, by End-user, 2017-2031
  • 12.4.1. Hospitals & Specialty Clinics
  • 12.4.2. Urgent Care or Outpatient Care
  • 12.4.3. Ambulatory Surgical Centers
  • 12.4.4. Military Medical Facilities
  • 12.4.5. Ambulance Services
• 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.5.1. Germany
  • 12.5.2. U.K.
  • 12.5.3. France
  • 12.5.4. Spain
  • 12.5.5. Italy
  • 12.5.6. Rest of Europe
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Product
  • 12.6.2. By Application
  • 12.6.3. By End-user
  • 12.6.4. By Country/Sub-region

13. Germany Chest Drainage Devices Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value & Volume Forecast, by Product, 2017-2031
  • 13.2.1. Thoracic Drainage Systems
    • 13.2.1.1. Analog
    • 13.2.1.2. Digital
  • 13.2.2. Trocar Drains
  • 13.2.3. Unsecured Needles
  • 13.2.4. Secured Needles
  • 13.2.5. Pleural Drainage Catheters
    • 13.2.5.1. PVC
    • 13.2.5.2. Others
  • 13.2.6. Thoracic Drainage Kits
• 13.3. Market Value Forecast, by Application, 2017-2031
  • 13.3.1. Thoracic Surgeries & Pulmonology
  • 13.3.2. Cardiac Surgeries
  • 13.3.3. General Intensive Care & Emergency Medicine
  • 13.3.4. Infectious Diseases
  • 13.3.5. Oncology & Pain Management
  • 13.3.6. Military/Damage Control/Disaster Medicine
• 13.4. Market Value Forecast, by End-user, 2017-2031
  • 13.4.1. Hospitals & Specialty Clinics
  • 13.4.2. Urgent Care or Outpatient Care
  • 13.4.3. Ambulatory Surgical Centers
  • 13.4.4. Military Medical Facilities
  • 13.4.5. Ambulance Services
• 13.5. Market Attractiveness Analysis
  • 13.5.1. By Product
  • 13.5.2. By Application
  • 13.5.3. By End-user

14. U.K. Chest Drainage Devices Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value & Volume Forecast, by Product, 2017-2031
  • 14.2.1. Thoracic Drainage Systems
    • 14.2.1.1. Analog
    • 14.2.1.2. Digital
  • 14.2.2. Trocar Drains
  • 14.2.3. Unsecured Needles
  • 14.2.4. Secured Needles
  • 14.2.5. Pleural Drainage Catheters
    • 14.2.5.1. PVC
    • 14.2.5.2. Others
  • 14.2.6. Thoracic Drainage Kits
• 14.3. Market Value Forecast, by Application, 2017-2031
  • 14.3.1. Thoracic Surgeries & Pulmonology
  • 14.3.2. Cardiac Surgeries
  • 14.3.3. General Intensive Care & Emergency Medicine
  • 14.3.4. Infectious Diseases
  • 14.3.5. Oncology & Pain Management
  • 14.3.6. Military/Damage Control/Disaster Medicine
• 14.4. Market Value Forecast, by End-user, 2017-2031
  • 14.4.1. Hospitals & Specialty Clinics
  • 14.4.2. Urgent Care or Outpatient Care
  • 14.4.3. Ambulatory Surgical Centers
  • 14.4.4. Military Medical Facilities
  • 14.4.5. Ambulance Services
• 14.5. Market Attractiveness Analysis
  • 14.5.1. By Product
  • 14.5.2. By Application
  • 14.5.3. By End-user

15. France Chest Drainage Devices Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value & Volume Forecast, by Product, 2017-2031
  • 15.2.1. Thoracic Drainage Systems
    • 15.2.1.1. Analog
    • 15.2.1.2. Digital
  • 15.2.2. Trocar Drains
  • 15.2.3. Unsecured Needles
  • 15.2.4. Secured Needles
  • 15.2.5. Pleural Drainage Catheters
    • 15.2.5.1. PVC
    • 15.2.5.2. Others
  • 15.2.6. Thoracic Drainage Kits
• 15.3. Market Value Forecast, by Application, 2017-2031
  • 15.3.1. Thoracic Surgeries & Pulmonology
  • 15.3.2. Cardiac Surgeries
  • 15.3.3. General Intensive Care & Emergency Medicine
  • 15.3.4. Infectious Diseases
  • 15.3.5. Oncology & Pain Management
  • 15.3.6. Military/Damage Control/Disaster Medicine
• 15.4. Market Value Forecast, by End-user, 2017-2031
  • 15.4.1. Hospitals & Specialty Clinics
  • 15.4.2. Urgent Care or Outpatient Care
  • 15.4.3. Ambulatory Surgical Centers
  • 15.4.4. Military Medical Facilities
  • 15.4.5. Ambulance Services
• 15.5. Market Attractiveness Analysis
  • 15.5.1. By Product
  • 15.5.2. By Application
  • 15.5.3. By End-user

16. Spain Chest Drainage Devices Market Analysis and Forecast

• 16.1. Introduction
  • 16.1.1. Key Findings
• 16.2. Market Value & Volume Forecast, by Product, 2017-2031
  • 16.2.1. Thoracic Drainage Systems
    • 16.2.1.1. Analog
    • 16.2.1.2. Digital
  • 16.2.2. Trocar Drains
  • 16.2.3. Unsecured Needles
  • 16.2.4. Secured Needles
  • 16.2.5. Pleural Drainage Catheters
    • 16.2.5.1. PVC
    • 16.2.5.2. Others
  • 16.2.6. Thoracic Drainage Kits
• 16.3. Market Value Forecast, by Application, 2017-2031
  • 16.3.1. Thoracic Surgeries & Pulmonology
  • 16.3.2. Cardiac Surgeries
  • 16.3.3. General Intensive Care & Emergency Medicine
  • 16.3.4. Infectious Diseases
  • 16.3.5. Oncology & Pain Management
  • 16.3.6. Military/Damage Control/Disaster Medicine
• 16.4. Market Value Forecast, by End-user, 2017-2031
  • 16.4.1. Hospitals & Specialty Clinics
  • 16.4.2. Urgent Care or Outpatient Care
  • 16.4.3. Ambulatory Surgical Centers
  • 16.4.4. Military Medical Facilities
  • 16.4.5. Ambulance Services
• 16.5. Market Attractiveness Analysis
  • 16.5.1. By Product
  • 16.5.2. By Application
  • 16.5.3. By End-user

17. Asia Pacific Chest Drainage Devices Market Analysis and Forecast

• 17.1. Introduction
  • 17.1.1. Key Findings
• 17.2. Market Value & Volume Forecast, by Product, 2017-2031
  • 17.2.1. Thoracic Drainage Systems
    • 17.2.1.1. Analog
    • 17.2.1.2. Digital
  • 17.2.2. Trocar Drains
  • 17.2.3. Unsecured Needles
  • 17.2.4. Secured Needles
  • 17.2.5. Pleural Drainage Catheters
    • 17.2.5.1. PVC
    • 17.2.5.2. Others
  • 17.2.6. Thoracic Drainage Kits
• 17.3. Market Value Forecast, by Application, 2017-2031
  • 17.3.1. Thoracic Surgeries & Pulmonology
  • 17.3.2. Cardiac Surgeries
  • 17.3.3. General Intensive Care & Emergency Medicine
  • 17.3.4. Infectious Diseases
  • 17.3.5. Oncology & Pain Management
  • 17.3.6. Military/Damage Control/Disaster Medicine
• 17.4. Market Value Forecast, by End-user, 2017-2031
  • 17.4.1. Hospitals & Specialty Clinics
  • 17.4.2. Urgent Care or Outpatient Care
  • 17.4.3. Ambulatory Surgical Centers
  • 17.4.4. Military Medical Facilities
  • 17.4.5. Ambulance Services
• 17.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 17.5.1. China
  • 17.5.2. Japan
  • 17.5.3. India
  • 17.5.4. Australia & New Zealand
  • 17.5.5. Rest of Asia Pacific
• 17.6. Market Attractiveness Analysis
  • 17.6.1. By Product
  • 17.6.2. By Application
  • 17.6.3. By End-user
  • 17.6.4. By Country/Sub-region

18. Latin America Chest Drainage Devices Market Analysis and Forecast

• 18.1. Introduction
  • 18.1.1. Key Findings
• 18.2. Market Value & Volume Forecast, by Product, 2017-2031
  • 18.2.1. Thoracic Drainage Systems
    • 18.2.1.1. Analog
    • 18.2.1.2. Digital
  • 18.2.2. Trocar Drains
  • 18.2.3. Unsecured Needles
  • 18.2.4. Secured Needles
  • 18.2.5. Pleural Drainage Catheters
    • 18.2.5.1. PVC
    • 18.2.5.2. Others
  • 18.2.6. Thoracic Drainage Kits
• 18.3. Market Value Forecast, by Application, 2017-2031
  • 18.3.1. Thoracic Surgeries & Pulmonology
  • 18.3.2. Cardiac Surgeries
  • 18.3.3. General Intensive Care & Emergency Medicine
  • 18.3.4. Infectious Diseases
  • 18.3.5. Oncology & Pain Management
  • 18.3.6. Military/Damage Control/Disaster Medicine
• 18.4. Market Value Forecast, by End-user, 2017-2031
  • 18.4.1. Hospitals & Specialty Clinics
  • 18.4.2. Urgent Care or Outpatient Care
  • 18.4.3. Ambulatory Surgical Centers
  • 18.4.4. Military Medical Facilities
  • 18.4.5. Ambulance Services
• 18.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 18.5.1. Brazil
  • 18.5.2. Mexico
  • 18.5.3. Rest of Latin America
• 18.6. Market Attractiveness Analysis
  • 18.6.1. By Product
  • 18.6.2. By Application
  • 18.6.3. By End-user
  • 18.6.4. By Country/Sub-region

19. Middle East & Africa Chest Drainage Devices Market Analysis and Forecast

• 19.1. Introduction
  • 19.1.1. Key Findings
• 19.2. Market Value & Volume Forecast, by Product, 2017-2031
  • 19.2.1. Thoracic Drainage Systems
    • 19.2.1.1. Analog
    • 19.2.1.2. Digital
  • 19.2.2. Trocar Drains
  • 19.2.3. Unsecured Needles
  • 19.2.4. Secured Needles
  • 19.2.5. Pleural Drainage Catheters
    • 19.2.5.1. PVC
    • 19.2.5.2. Others
  • 19.2.6. Thoracic Drainage Kits
• 19.3. Market Value Forecast, by Application, 2017-2031
  • 19.3.1. Thoracic Surgeries & Pulmonology
  • 19.3.2. Cardiac Surgeries
  • 19.3.3. General Intensive Care & Emergency Medicine
  • 19.3.4. Infectious Diseases
  • 19.3.5. Oncology & Pain Management
  • 19.3.6. Military/Damage Control/Disaster Medicine
• 19.4. Market Value Forecast, by End-user, 2017-2031
  • 19.4.1. Hospitals & Specialty Clinics
  • 19.4.2. Urgent Care or Outpatient Care
  • 19.4.3. Ambulatory Surgical Centers
  • 19.4.4. Military Medical Facilities
  • 19.4.5. Ambulance Services
• 19.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 19.5.1. Brazil
  • 19.5.2. Mexico
  • 19.5.3. Rest of Latin America
• 19.6. Market Attractiveness Analysis
  • 19.6.1. By Product
  • 19.6.2. By Application
  • 19.6.3. By End-user
  • 19.6.4. By Country/Sub-region

20. Competition Landscape

• 20.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 20.2. Market Share Analysis By Company (2022)
• 20.3. List of Key Players by Product Category
• 20.4. Company Profiles
  • 20.4.1. ATMOS MedizinTechnik GmbH & Co. KG
    • 20.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.1.2. Product Portfolio
    • 20.4.1.3. Financial Overview
    • 20.4.1.4. SWOT Analysis
    • 20.4.1.5. Strategic Overview
  • 20.4.2. Becton, Dickinson and Company (BD)
    • 20.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.2.2. Product Portfolio
    • 20.4.2.3. Financial Overview
    • 20.4.2.4. SWOT Analysis
    • 20.4.2.5. Strategic Overview
  • 20.4.3. Cardinal Health, Inc.
    • 20.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.3.2. Product Portfolio
    • 20.4.3.3. Financial Overview
    • 20.4.3.4. SWOT Analysis
    • 20.4.3.5. Strategic Overview
  • 20.4.4. Cook Medical
    • 20.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.4.2. Product Portfolio
    • 20.4.4.3. Financial Overview
    • 20.4.4.4. SWOT Analysis
    • 20.4.4.5. Strategic Overview
  • 20.4.5. Getinge AB
    • 20.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.5.2. Product Portfolio
    • 20.4.5.3. Financial Overview
    • 20.4.5.4. SWOT Analysis
    • 20.4.5.5. Strategic Overview
  • 20.4.6. ICU Medical, Inc.
    • 20.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.6.2. Product Portfolio
    • 20.4.6.3. Financial Overview
    • 20.4.6.4. SWOT Analysis
    • 20.4.6.5. Strategic Overview
  • 20.4.7. Medela AG
    • 20.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.7.2. Product Portfolio
    • 20.4.7.3. Financial Overview
    • 20.4.7.4. SWOT Analysis
    • 20.4.7.5. Strategic Overview
  • 20.4.8. Medtronic
    • 20.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.8.2. Product Portfolio
    • 20.4.8.3. Financial Overview
    • 20.4.8.4. SWOT Analysis
    • 20.4.8.5. Strategic Overview
  • 20.4.9. Redax S.p.a.
    • 20.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.9.2. Product Portfolio
    • 20.4.9.3. Financial Overview
    • 20.4.9.4. SWOT Analysis
    • 20.4.9.5. Strategic Overview
  • 20.4.10. Rocket Medical plc.
    • 20.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.10.2. Product Portfolio
    • 20.4.10.3. Financial Overview
    • 20.4.10.4. SWOT Analysis
    • 20.4.10.5. Strategic Overview
  • 20.4.11. Sinapi Biomedical
    • 20.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.11.2. Product Portfolio
    • 20.4.11.3. Financial Overview
    • 20.4.11.4. SWOT Analysis
    • 20.4.11.5. Strategic Overview
  • 20.4.12. Teleflex Incorporated
    • 20.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.12.2. Product Portfolio
    • 20.4.12.3. Financial Overview
    • 20.4.12.4. SWOT Analysis
    • 20.4.12.5. Strategic Overview
  • 20.4.13. Utah Medical Products, Inc.
    • 20.4.13.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.13.2. Product Portfolio
    • 20.4.13.3. Financial Overview
    • 20.4.13.4. SWOT Analysis
    • 20.4.13.5. Strategic Overview
  • 20.4.14. Vygon SAS
    • 20.4.14.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 20.4.14.2. Product Portfolio
    • 20.4.14.3. Financial Overview
    • 20.4.14.4. SWOT Analysis
    • 20.4.14.5. Strategic Overview

관련자료